Search Results 81-90 of 16663 for ������������KA���:ZA31���24������ ���������������������������������

  1. Publications - Kari A. Martin, M.D. - Mayo Clinic

    Current Psychiatry. 2012; 11(7):45-6. Martin KA, Bostwick JM, Vargas HE. Liver transplant case report: Transgenderism and liver transplantation ...

  2. Publications - Max A. Hawkes, M.D. - Mayo Clinic

    2018 Jan; 8 (1):24-28 Epub 2017 Sept 27. View PubMed; Hawkes MA, Wilken M, Vazquez G, Farez MF. Age may contribute to the increased frequency of axonal ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Has anyone taken Lynparza? 24 Replies Sat, Jun 07, 2025. See more discussions. Related. Breast cancer chemoprevention · Breast Cancer Education Tool · Breast ...

  4. Publications - Dimitar K. Gavrilov, M.D., Ph.D. - Mayo Clinic

    Epub 2024 Mar 24. View PubMed; Hall PL, Liedke K ... KA, Peterson C, Pettersen RD, Pitt JJ, Poh S ... 1991; (24):219. View PubMed; Gavrilov DK ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  6. Publications - Nirvi Dahiya, M.D. - Mayo Clinic

    Comparative sensitivity and accuracy of 24 vs. ... KA, Menias CO. Spectrum of imaging findings in ... 2017 Nov - Dec; 24 (7):1170-1176 Epub 2017 July 08

  7. Publications

    2001 Jan; 24(1):60-3. ... Pranzatelli MR, Hanin I, Tate E, Kindel G, Bergin A, Brown CM, Habersang P, Habersang R, Mack KJ, Rosenbaum B, Selby KA, Vasconcellos M.

  8. Selected Publications by Faculty and Fellows Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Sc

    Biology Of Blood And Marrow Transplantation. 2018 Mar; 24(3 Suppl 1): S385 [Meeting Abstract]. Mayo Authors: Gea Banacloche, JC InfD - Phoenix. Source ...

  9. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

    Subjects receiving treatment with sotatercept are eligible only if on a stable dose of sotatercept for at least 24 weeks prior to and throughout Screening ...

  10. Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-011889; Jacksonville, Florida: 24-011889. NCT ID: NCT06158841. Sponsor Protocol Number: M22-574. About this study. The purpose ...